A detailed history of Pier 88 Investment Partners LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 121,610 shares of PYXS stock, worth $205,520. This represents 0.59% of its overall portfolio holdings.

Number of Shares
121,610
Previous 113,700 6.96%
Holding current value
$205,520
Previous $376,000 18.62%
% of portfolio
0.59%
Previous 0.43%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$2.83 - $3.94 $22,385 - $31,165
7,910 Added 6.96%
121,610 $446,000
Q2 2024

Aug 06, 2024

BUY
$3.06 - $5.58 $190,760 - $347,857
62,340 Added 121.38%
113,700 $376,000
Q1 2024

May 10, 2024

BUY
$2.03 - $6.59 $104,260 - $338,462
51,360 New
51,360 $218,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Pier 88 Investment Partners LLC Portfolio

Follow Pier 88 Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.